Chargement en cours...
Effect of beraprost on pulmonary hypertension due to left ventricular systolic dysfunction
Beraprost is used to treat peripheral chronic arterial occlusive disease. However, the efficacy and safety of beraprost in patients with pulmonary hypertension (PH) due to left ventricular systolic dysfunction (PH-HFrEF) remains unknown. The primary objective of this study was to determine the effec...
Enregistré dans:
| Publié dans: | Medicine (Baltimore) |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494404/ https://ncbi.nlm.nih.gov/pubmed/31008926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000014965 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|